- Home
- VKTX vs FBK Comparison
VKTX vs FBK Comparison
Compare VKTX & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VKTX | FBK |
|---|---|---|
| Founded | 2012 | 1906 |
| Country | United States | United States |
| Employees | 53 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.0B |
| IPO Year | 2014 | 2016 |
Fundamental Metrics
Financial Performance| Metric | VKTX | FBK |
|---|---|---|
| Price | $32.42 | $54.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $88.00 | $61.75 |
| AVG Volume (30 Days) | ★ 2.8M | 207.8K |
| Earning Date | 05-14-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 2.45 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $43.54 |
| Revenue Next Year | N/A | $7.86 |
| P/E Ratio | ★ N/A | $22.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.92 | $38.83 |
| 52 Week High | $43.15 | $62.37 |
Technical Indicators
Market Signals| Indicator | VKTX | FBK |
|---|---|---|
| Relative Strength Index (RSI) | 52.17 | 34.67 |
| Support Level | $30.73 | $52.13 |
| Resistance Level | $35.66 | $55.81 |
| Average True Range (ATR) | 1.79 | 1.79 |
| MACD | 0.29 | -0.58 |
| Stochastic Oscillator | 51.79 | 19.26 |
Price Performance
Historical ComparisonAbout VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.